Community/Retail

Totaling more than 2 million, women comprise the fastest-growing group within the veteran population.

Allergy analysis and interpretation is a fundamental component of a health-system pharmacist's day.

This is the first major update to the definition of sepsis since 2001.

OTC and prescription drug mascots may play a larger-than-expected role in patients' health care decisions.

A cancer-related death has been linked to talc-based baby powder manufactured by Johnson & Johnson.

Hiring the best candidate isn't easy, but it's one of the most important aspects of running a successful pharmacy.

The FDA today approved Pfizer's tofacitinib citrate (Xeljanz) extended-release tablets, the first and only once-daily oral Janus kinanse inhibitor for treating rheumatoid arthritis.

Dan Benamoz, RPh, President and CEO of Pharmacy Development Services, discusses the challenges independent pharmacists face with respect to customer retention efforts.

The National Association of Chain Drug Stores has named as its new director of federal government affairs Vonnie Hampel.

Nonadherence to chronic obstructive pulmonary disease treatment worsens patient health outcomes and increases related costs.

California's first surplus prescription medication program recently opened its doors.

McKesson has announced the launch of its new Drug Spend Intelligence tool, which provides the information needed to identify purchase trends, evaluate the impact of price fluctuations, and implement and track clinical initiatives.

The FDA has accepted for review Sanofi's new drug application for its fixed-ratio combination of basal insulin glargine 100 units/mL and lixisenatide for the treatment of type 2 diabetes.

Community pharmacists are in regular communication with patients about their medication therapies.

Relaxation drinks are marketed as safe, nonalcoholic supplements that help the user unwind.

A 2017 PharmD candidate at the University of Cincinnati will be recognized at this year's American Pharmacists Association annual meeting for winning the Good Government Student Pharmacist-of-the-Year Award.

A Texas compounding pharmacy called Pharmacy Solutions will pay $85,000 to settle a pregnancy discrimination lawsuit.

Iroko Pharmaceuticals' meloxicam (Vivlodex) capsules, designed to treat osteoarthritis pain, are now available by prescription at pharmacies across the United States.

Have you checked up on your personal brand lately?

No one is guaranteed golden years.

The Biosimilars Council, a division of the Generic Pharmaceutical Association today announced its 2016 Board of Directors.

The National Community Pharmacists Association endorsed a range of solutions to the prescription drug abuse epidemic and asked lawmakers to revise an overly restrictive "lock-in pharmacy" proposal limiting Medicare beneficiary access.

U.S. Reps. Doug Collins (R-Ga.) and Dave Loebsack (D-Iowa), who are the original sponsors of H.R. 244, were joined by 14 other members of Congress in a letter to the chairs and ranking members of the U.S. House of Representatives Energy and Commerce, Ways and Means, and Armed Services committees urging greater transparency in generic prescription drug reimbursements for governmental health programs.

The American Pharmacists Association (APhA) Foundation today announced 22 recipients of its 2016 Incentive Grants.

CVS Health has announced that prescription drug trend for CVS Health pharmacy benefit management clients dropped dramatically to 5% in 2015 from a high of 11.8% in 2014.

Sanofi has announced that the license and development agreement between it and Kaléo, the developer of Auvi-Q, will terminate later this year.

Meijer has announced that it is changing the name of its LPGA tournament to the Meijer LPGA Classic for Simply Give in an effort to focus on its cause of stocking local food pantries.

Prevalence of gastroschisis, a birth defect where a baby's intestines stick outside the body, is increasing in the United States.

Pharmacist involvement on care teams for geriatric patients transitioning out of emergency departments may still be undervalued.

Pharmakon Pharmaceuticals has issued a voluntary recall of a morphine product that is super potent.